CAV3 and type 2 diabetes mellitus: A previous assessment of patients with newly developed T2DM demonstrated that K15N muta tion located in the N-terminus of caveolin-3 may lead to changes in caveolin-3 secondary structure, thus causing decreased recombinant caveolin-3 expression [97].